How Technical Transfer and Programme Management Work Together to Deliver Successful Product Development
Upperton advances sterile manufacturing facility following MHRA submission.
Insight
The Art and Science of Tech Transfer
Upperton advances sterile manufacturing facility following MHRA submission.
Why Spray Drying Is Gaining Attention as a Biologics Lifecycle Management Strategy
Upperton advances sterile manufacturing facility following MHRA submission.
Influence of L-Leucine Content on the Internal and External Morphology of Spray-Dried Particles
Upperton advances sterile manufacturing facility following MHRA submission.
Risk Isn’t Inevitable: How the Right CDMO Partnership Protects Your Programme
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Liquid Injectables: Stability Issues and How to Avoid Them
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How are Parenteral Manufacturing Solutions Evolving to Meet the Demands for More Specialised and Sensitive Drug Formulations?
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
How Upperton Has Evolved to Meet the Changing Needs of Biotechs
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
What Biotech Startups Need to Know About Sterile Fill-Finish Services
What exactly is the difference between a CDMO, a CRO, and a CMO? Each plays a vital role in the life sciences ecosystem.
Low Bioburden Powders for Terminal Sterilisation: Raising the Standard in Modern Drug Development
The pressure of speed to clinic is continuing to increase. Biotechs are under more pressure, and therefore the CDMOs supporting them must evolve too